Table 4 Factors predicting vascular access created timely with renal function expressed by Cr, MDRD-eGFR and CG-eGFR.
Variable | Adjusted OR (95% CI) | P value | Adjusted OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
---|---|---|---|---|---|---|
Sex | ||||||
Female | 1.00 (reference) | |||||
Male | 2.02 (1.23, 3.31) | 0.005 | ||||
Age at VA creation | 0.97 (0.95, 0.99) | 0.008 | ||||
Renal function at VA creation | ||||||
By Cr (mg/dL) | 0.81 (0.74, 0.89) | < 0.001 | ||||
By eGFR (MDRD) (ml/min/1.73 m2) | 1.27 (1.11, 1.46) | 0.001 | ||||
By eGFR (CG) (ml/min/1.73 m2) | 1.24 (1.11, 1.39) | < 0.001 | ||||
eGFR slope (ml/min/1.73 m2 per year)* | 0.001# | 0.008# | 0.001# | |||
Q1 (< − 7.79) | 0.37 (0.19, 0.73) | 0.004 | 0.46 (0.24, 0.86) | 0.015 | 0.38 (0.20, 0.72) | 0.003 |
Q2 (− 7.79 ~ < − 4.30) | 1.28 (0.61, 2.72) | 0.5 | 1.30 (0.62, 2.72) | 0.5 | 1.22 (0.58, 2.54) | 0.6 |
Q3 (− 4.30 ~ < − 2.44) | 1.00 (reference) | – | 1.00 (reference) | – | 1.00 (reference) | – |
Q4 (≥ − 2.44) | 0.97 (0.49, 1.93) | 0.9 | 0.95 (0.48, 1.87) | 0.9 | 1.02 (0.52, 2.03) | 0.9 |